Investigation and management of congestive heart failure

BMJ (Online)

Volumn 341, Issue 7765, 2010, Pages 190-195

  Arroll, Bruce ^a   Doughty, Robert ^a   Andersen, Victoria ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BRAIN NATRIURETIC PEPTIDE; CAPTOPRIL; CARVEDILOL; CILAZAPRIL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FOSINOPRIL; LISINOPRIL; METOPROLOL SUCCINATE; NEBIVOLOL; PERINDOPRIL; QUINAPRIL; RAMIPRIL;

CLINICAL ASSESSMENT; CONGESTIVE HEART FAILURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE TOLERANCE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; PRIORITY JOURNAL; REVIEW;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DIAGNOSIS, DIFFERENTIAL; DIGOXIN; DIURETICS; DYSPNEA; ECHOCARDIOGRAPHY; EDEMA; EXERCISE TOLERANCE; FEMALE; HEART FAILURE; HUMANS; MALE; MINERALOCORTICOID RECEPTOR ANTAGONISTS; NATRIURETIC PEPTIDE, BRAIN; PATIENT EDUCATION AS TOPIC; REFERRAL AND CONSULTATION; TERMINAL CARE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77955104838     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c3657     Document Type: Review

References (30)

1. National Institute for Health and Clinical Excellence. Chronic heart failure. 2003. http://guidance.nice.org.uk/CG5/Guidance/pdf/English.
2. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993;88:107-15.
3. Mant J, Doust J, Roalfe A, Barton P, Cowie MR, Glasziou P, et al. Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care. Health Technol Assess 2009;13(32). www.hta.ac.uk/project/1509. asp.
4. Chronic congestive heart failure. BMJ Best Practicehttp://bestpractice. bmj.com/best-practice/monograph/61.html.
5. Chen YT, Vaccarino V, Williams CS, Butler J, Berkman LF, Krumholz HM. Risk factors for heart failure in the elderly: a prospective community-based study. Am J Med 1999;106:605-12.
6. Mckee PA, Castelli WP, McNamara PA, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971;285:1441-6.
7. Heart Failure Society of America. The stages of heart failure - NYHA classification. www.abouthf.org/questions-stages.htm.
8. Calvert MJ, Shankar A, McManus RJ, Ryan R, Freemantle N. Evaluation of the management of heart failure in primary care. Fam Pract 2009;26:145-53.
9. Poole-Wilson PA, Swedberg K, Cleland JG, Di Lendarda A, Hanrath P, Komajda M, et al. A comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the comet trial randomised controlled trial. Lancet 2003;362:7-13.
10. Massie BM, Armstrong PW, Cleland JG, Horowitz JD, Packer M, Poole-Wilson PA, et al. Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival. Arch Intern Med 2001;161:165-71.
11. Konstam MA, Neaton JD, Dickstein K, Drexler H, Komajda M, Martinez FA, et al. Effects of high-dose versus low dose losartan on clinical outcomes in patients with heart failure (HEAAL study) a randomised, double blind trial. Lancet 2009;374:1840-8.
12. European Society of Cardiology, Heart Failure Association of the ESC, European Society of Intensive Care. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: Eur J Heart Failure 2008;10:933-89.
13. Salpeter SR, Ormiston TM, Salpeter EE. Cardioselective beta-blockers for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2005;4:CD003566.
14. Wald DS, More RS, Martin M, Hughes L, Reid CJ. Can beta blockers be safely initiated at home in patients with heart failure. Q J Med 2002 2002;95:55-9.
15. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. randomized aldactone evaluation study investigators. N Engl J Med 1999;341:709-17.
16. Ezekowitz JA, McAlister FA. Aldosterone blockade and left ventricular dysfunction: a systematic review of randomized clinical trials. Eur Heart J 2009.30:469-7.
17. Meyer P, White M, Mujib A, Nozza T, Love I, Aban J, et al. Digoxin and reduction of heart failure hospitalization in chronic systolic and diastolic heart failure. Am J Cardiol 2008;102:1681-6.
18. Hood WB, Dans AL, Guyatt GH, Jaeschke R, McMurray JJ. Digitalis for treatment of congestive heart failure in patients in sinus rhythm. Cochrane Database Syst Rev 2004;2:CD002901.
19. Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Management of Heart Failure in Adults; with the International Society for Heart and Lung Transplantation. The diagnosis and management of heart failure in adults. a focused update. J Am Coll Cardiol 2009;53:1343-82.
20. CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003;362:777-81.
21. I-PRESERVE Investigators. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 2008;359:2456-67.
22. Lafuente-Lafuente C, Mahe I, Extramiana F. Management of atrial fibrillation. BMJ 2010;339:b5216.
23. Scottish Intercollegiate Guideline Network. The management of chronic heart failure. 2007. www.sign.ac.uk/pdf/sign95.pdf.
24. Emberson JR, Ng LL, Armitage J, Bowman L, Parish S, Collins R, Heart Protection Study Collaborative Group. N-terminal pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20 536 patients in the MRC/BHF heart protection study. J Am Coll Cardiol 2007;49:311-9.
25. McKelvie R. Heart failure. Clin Evid 2010; http://clinicalevidence.bmj. com/ceweb/conditions/cvd/0204/0204.jsp.
26. Doughty RN, Wright SP, Pearl A, Walsh HJ, Muncaster S, Whalley GA, et al. Randomized, controlled trial of integrated heart failure management: the Auckland Heart Failure Management Study. Eur Heart J 2002;23:139-46. (Pubitemid 35204232)
27. Brophy JM, Dagenais GR, McSherry F, Williford W, Yusuf S. A multivariate model for predicting mortality in patients with heart failure and systolic dysfunction. Am J Med 2004;116:300-4.
28. Koelling TM, Joseph S, Aaronson KD. Heart failure survival score continues to predict clinical outcomes in patients with heart failure receiving beta-blockers. J Heart Lung Transplant 2004;23:1414-22. (Pubitemid 40018165)
29. Gott M, Small N, Barnes S, Payne S, Seamark D. Older peoples views of a good death in heart failure. Implications for palliative care provision. Soc Sci Med 2008;67:1113-21.
30. Sloan J. A bitter pill: how the medical system is failing the elderly. Greystone Books, D & M Publishers, 2009.